Skip to main content
. 2007 Dec 21;111(5):2563–2572. doi: 10.1182/blood-2007-10-116186

Table 2.

Characteristics of 200 adult patients with non-L3 ALL, by karyotype category

Characteristic Normal diploid, N = 31 t(9;22)/BCR/ABL1, N = 36 Other unfavorable, N = 19 Miscellaneous, N = 54 Nonevaluable, N = 60 All patients, N = 200
Sex, no. (%)
    Female 12 (39) 19 (53) 8 (42) 17 (31) 23 (38) 79 (40)
    Male 19 (61) 17 (47) 11 (58) 37 (69) 37 (62) 121 (61)
Race, no. (%)
    Black 2 (6) 3 (8) 2 (11) 5 (9) 2 (3) 14 (7)
    Hispanic 10 (32) 7 (19) 1 (5) 16 (30) 16 (27) 50 (25)
    White, non-Hispanic 18 (58) 24 (67) 14 (74) 30 (56) 36 (60) 122 (61)
    Other 1 (3) 2 (6) 2 (11) 3 (6) 6 (10) 14 (7)
Performance status, no. (%)
    0 to 1 29 (94) 33 (92) 18 (95) 50 (93) 52 (87) 182 (91)
    2 to 3 2 (6) 3 (8) 1 (5) 4 (7) 8 (13) 18 (9)
FAB classification (local diagnosis), no. (%)
    L1 14 (45) 9 (25) 5 (26) 20 (37) 29 (48) 77 (39)
    L2 16 (52) 24 (67) 12 (63) 29 (54) 26 (43) 107 (54)
    Other, NOS 1 (3) 3 (8) 2 (11) 5 (9) 5 (8) 16 (8)
Median, age, y (range) 25 (18-57) 47 (17-64) 31 (18-55) 29 (17-63) 38 (16-65) 32 (16-65)
Median, WBCs, 1000/mm3, (range) 11.5 (0.9-150.0) 38.9 (1.4-141.3) 22.5 (5.2-163.0) 14.4 (0.6-396.6) 5.2 (1.1-197.5) 15.8 (0.6-396.6)
Peripheral blasts, % 59 (0-91) 64 (0-95) 64 (20-97) 49 (0-98) 24 (0-92) 52 (0-98)
Median peripheral blasts, 1000/mm3, (range) 5.6 (0.0-136.5) 29.3 (0.0-125.3) 12.9 (1.6-124.9) 7.5 (0.0-141.9) 1.2 (0.0-173.8) 8.1 (0.0-173.8)
Median hemoglobin, g/dL, (range) 9.4 (4.7-18.2) 9.9 (5.5-13.4) 10.1 (7.0-14.1) 9.4 (4.6-16.5) 9.2 (4.2-18.2) 9.7 (4.2-18.2)
Median platelets, 1000/mm3, (range) 70 (16-675) 36 (3-400) 47 (10-171) 48 (5-324) 47 (3-371) 48 (3-675)
Marrow blasts, % 90 (32-99) 88 (48-99) 78 (38-95) 89 (2-99) 92 (17-99) 90 (2-99)

NOS indicates not otherwise specified; and WBC, white blood cells.